- NHL Treatment
- Hodgkin's Treatment
- Clinical Trials
- Monoclonal Antibodies
- Types of NHL
Lymphoma and Pets
Health Insurance and Quality of Cancer Treatment
The investigators examined the association between treatment received and insurance status - private insurance, any Medicaid, Medicare only, or no insurance - for 10 common cancers with established evidence-based treatment guidelines. They also adjusted for other clinical and non-clinical factors such as cancer stage at diagnosis, comorbidities, age, race, and marital status.
Levels of guidelines-based treatment proved to be lower than expected for all groups, but were significantly lower for patients who depended on Medicare or Medicaid alone for insurance. Also of particular note is that non-Hispanic black patients with Medicaid were significantly less likely than other groups to receive guidelines-based treatment, with only half receiving recommended therapy.
The investigators concluded that health insurance is one of many important variables that influence the receipt of guidelines-based therapy. In a follow-up study, they plan to examine how insurance status affects survival after cancer diagnosis. Source: US NCI